Clinical trials - Press Releases

Date	Title	Company
05-May-2022	Novotech Acquires US CRO NCGS, Expands Global Expertise	Novotech Health Holdings Pte Ltd
04-May-2022	Phesi global analysis of 2.5 million patients finds participants in breast cancer clinical trials are getting younger	Phesi
03-May-2022	BioXcel Therapeutics Announces First Patient Dosed in TRANQUILITY II Phase 3 Trial for Acute Treatment of Agitation in Patients with Alzheimer’s Disease	BioXcel Therapeutics
03-May-2022	JYSELECA®▼ (filgotinib), recommended by the Health Service Executive (HSE) for people with Ulcerative Colitis (UC) in Ireland	Galapagos Biotech LTD
28-Apr-2022	AARDEX® Group adds etectRx to their MEMS® Adherence Hardware ecosystem	AARDEX® Group
26-Apr-2022	Priothera Receives FDA clearance of Investigational New Drug (IND) to start Phase 2b/3 study with mocravimod in Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HSCT)	Priothera
25-Apr-2022	Mundipharma and Cidara Therapeutics Announce First Presentation of Results from Global Phase 3 ReSTORE Trial of Rezafungin for Treatment of Candidemia and/or Invasive Candidiasis Demonstrating its Positive Efficacy and Safety Profile	Mundipharma and Cidara
21-Apr-2022	Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion across the UK and Western Europe	Panthera Biopartners
20-Apr-2022	ProQR Announces Additional Sepofarsen Illuminate Trial Analyses and Provides Update on Company Strategy	ProQR Therapeutics N.V.
19-Apr-2022	PHASTAR Names Ping-Chung Chang as Head of China Development and Global Delivery	PHASTAR
19-Apr-2022	Clinerion adds Patient Network Explorer coverage to three new hospitals in Brazil, bringing the Brazilian total to 22 hospitals and over 8 million patients.	Clinerion Ltd.
19-Apr-2022	Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 - Best Contract Research Organization in APAC	Avance Clinical
12-Apr-2022	Omnix Medical Starts Phase I Clinical Trial of Novel Anti-Infective; First Healthy Volunteers Dosed	Omnix Medical
11-Apr-2022	CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities	CluePoints
07-Apr-2022	AZD8233 reduced low-density lipoprotein cholesterol levels by 73% in patients with high-risk hypercholesterolemia in ETESIAN Phase IIb trial	AstraZeneca
07-Apr-2022	Celsion and Medidata to Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial	Celsion
06-Apr-2022	FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA	SMi Group
06-Apr-2022	Early access issued for eligible patients in the UK for radioligand therapy in advanced prostate cancer	Advanced Accelerator Applications (AAA), a Novartis company.
05-Apr-2022	Achilles Therapeutics to Host KOL Webcast to Highlight TRACERx Study Presentations from the 2022 AACR Annual Meeting	Achilles Therapeutics
05-Apr-2022	DIAMOND trial: Veltassa® enables patients to achieve long-term potassium control and optimized RAASi therapy	Vifor Pharma